Tag: generative artificial intelligence (ai) in drug discovery market forecast

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Generative Artificial Intelligence (AI) In Drug Discovery Market from 2024 to 2033?
The market for generative AI in drug discovery has seen exponential growth, projected to increase from $0.15 billion in 2023 to $0.19 billion in 2024, at a CAGR of 30.6%. Contributing factors include the rising incidence of chronic diseases, advancements in drug discovery and clinical trials, support for AI in healthcare, growth in biotech industries, and increased governmental backing.

The generative AI in drug discovery market is anticipated to witness exponential growth, expanding to $0.57 billion by 2028 at a CAGR of 30.7%. This increase is fueled by the demand for cost-effective drug discovery, enhanced collaborations among industry players, rising computational capabilities, the integration of generative AI with other technologies, and expedited drug development processes. Prominent trends include technological advancements, the merging of generative AI with experimental biology, high-throughput screening, and the growing use of cloud-based AI solutions.

Claim Your Free Sample of the Global Generative Artificial Intelligence (AI) In Drug Discovery Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16067&type=smp

What Key Factors Are Fueling the Growth of the Generative Artificial Intelligence (AI) In Drug Discovery Market?
The rising number of clinical trials is likely to stimulate the growth of generative AI in the drug discovery market. Clinical trials evaluate new medical treatments and gather crucial data. The increase in trials is due to advancements in research and regulatory changes. Data from clinical trials supports generative AI models, accelerating drug discovery. By the end of 2023, over 477,000 clinical trials were registered globally. Therefore, the rise in clinical trials is driving generative AI in drug discovery.

What Are the Major Segments of the Generative Artificial Intelligence (AI) In Drug Discovery Market?
1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

What New Trends Are Transforming the Generative Artificial Intelligence (AI) In Drug Discovery Market?
Firms in the generative AI in drug discovery market are developing AI tools to streamline drug discovery processes. In May 2023, Google Cloud launched the Target and Lead Identification Suite and the Multiomics Suite to enhance drug development and precision medicine.

Order Now for Fast Delivery of Your Generative Artificial Intelligence (AI) In Drug Discovery Market Report!
https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-drug-discovery-global-market-report

Which Regions Are Driving Growth in the Generative Artificial Intelligence (AI) In Drug Discovery Market?
North America was the largest region in the generative AI in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the generative artificial intelligence (ai) in drug discovery market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Generative Artificial Intelligence (AI) In Drug Discovery Market Include

1. Generative Artificial Intelligence (AI) In Drug Discovery Market Executive Summary
2. Generative Artificial Intelligence (AI) In Drug Discovery Market Segments
3. Generative Artificial Intelligence (AI) In Drug Discovery Market Size And Template Market Growth Rate
4.  Key Generative Artificial Intelligence (AI) In Drug Discovery Market Trends
5. Major Generative Artificial Intelligence (AI) In Drug Discovery Market Drivers
……
25. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market
26. Top Generative Artificial Intelligence (AI) In Drug Discovery Companies
27. Generative Artificial Intelligence (AI) In Drug Discovery Market Opportunities And Strategies
28. Generative Artificial Intelligence (AI) In Drug Discovery Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Generative Artificial Intelligence Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-sports-global-market-report

Generative Artificial Intelligence In Development And Operations (DevOps) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-in-development-and-operations-devops-global-market-report

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024, the generative artificial intelligence (AI) in drug discovery market is expected to show promising growth in the forecast period.

Market Growth Overview

• Rapid Expansion: The generative AI in drug discovery market has seen significant growth recently.
• 2023 to 2024: Market size will grow from $0.15 billion in 2023 to $0.19 billion in 2024, reflecting a robust compound annual growth rate (CAGR) of 30.6%.
• Future Projections: By 2028, the market is expected to reach $0.57 billion, maintaining a strong CAGR of 30.7%.

Key Drivers of Growth

• Rising Chronic Diseases: Increased prevalence of chronic diseases is boosting demand for advanced drug discovery methods.
• AI Integration: Growing support for integrating AI into healthcare and drug development enhances market expansion.
• Biotech Industry Growth: Expansion of biotech industries and government support are contributing to market growth.

Growth Trends and Predictions

• Cost-Effective Solutions: Demand for cost-effective drug discovery methods drives the adoption of generative AI.
• Collaborations and Technology: Increasing collaborations among market players and advancements in computational power are accelerating growth.
• Integration with Emerging Technologies: The integration of generative AI with technologies like high-throughput screening and experimental biology is transforming drug discovery.

View More On The Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-drug-discovery-global-market-report

Rising Clinical Trials Impact

• Increasing Trials: The number of clinical trials is on the rise, propelling the growth of generative AI in drug discovery.
• Clinical Trials Data: Clinical trial data enhances AI models, speeding up drug discovery by predicting interactions and designing compounds.
• Global Data Growth: As of the end of 2023, there were 477,234 clinical trials registered globally, up from 437,512 in 2022, highlighting the growing importance of clinical trials in AI-driven drug discovery.

Major Companies and Innovations

• Leading Players: Key companies in the market include Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, and Schrödinger Inc.
• Advanced AI Tools: Companies are developing AI-powered tools that streamline drug discovery and development processes. For example:
  • Google Cloud Innovations: Google Cloud introduced the Target and Lead Identification Suite and the Multiomics Suite in May 2023, enhancing drug discovery and precision medicine.

Notable Acquisitions

• Recursion Pharmaceuticals: In May 2023, Recursion Pharmaceuticals acquired Cyclica and Valence, enhancing its AI-driven drug discovery capabilities. This positions Recursion as a key player in the industry, leveraging advanced technologies for innovative drug discovery.

Market Segmentation

• By Type: The market is segmented into Small Molecule and Large Molecule.
• By Technology: Key technologies include Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, and Quantum Computing.
• By End-User: The market serves Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and other end-users.

Regional Insights

• North America: The largest market region in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period, driven by increasing investments and research activities in the region.

Generative AI is set to revolutionize drug discovery and precision medicine, offering exciting opportunities for accelerating drug development and improving patient outcomes. With continued advancements and increasing adoption, the market is poised for remarkable growth in the coming years.

Request A Sample Of The Global Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16067&type=smp